TD Cowen raised the firm’s price target on Alpha Teknova (TKNO) to $10 from $8 and keeps a Buy rating on the shares. The firm provided a Q4 preview for the Life Science Tools sector where positive signs related to R&D spend, elongated sales cycles, and inventory de-stocking are likely to fight for attention with concerns over NIH, China, and policy uncertainty.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
